DRESS syndrome

Synonyms
DIHS, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, DRESS
Specialty
Internal medicine · Allergology
Images
Clinical 2
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Aetiopathogenesis
  4. Clinical features
  5. Diagnosis
  6. Treatment principles
  7. Keep learning in the app
  8. Further reading (open access)
  9. Cross-references

Images (2)

DRESS syndrome – clinical photo: DRESS syndrome: extensive maculopapular rash on the back, coalescing into larger patches
DRESS syndrome: extensive maculopapular rash on the back, coalescing into larger patchesImage: Ureche C, Moldovan DL, Vița I, Guila V, Nicola-Varo T (Reports 2025) (PubMed Central) · CC BY 4.0 · Source
DRESS syndrome – clinical photo: DRESS syndrome: dense morbilliform rash on the abdomen (upper and lower), epidermis without blisters or necrosis
DRESS syndrome: dense morbilliform rash on the abdomen (upper and lower), epidermis without blisters or necrosisImage: Ureche C, Moldovan DL, Vița I, Guila V, Nicola-Varo T (Reports 2025) (PubMed Central) · CC BY 4.0 · Source
1 / 2

Definition

DRESS syndrome (drug reaction with eosinophilia and systemic symptoms), also called drug-induced hypersensitivity syndrome (DIHS), is a severe, delayed-onset type IV (T cell-mediated) drug reaction. It is characterised by rash, fever, marked eosinophilia and involvement of internal organs. Together with Stevens-Johnson syndrome, toxic epidermal necrolysis and acute generalised exanthematous pustulosis (AGEP), it is one of the severe cutaneous adverse drug reactions.

Aetiopathogenesis

  • Typical triggers: frequently caused by antiepileptic drugs (including carbamazepine, phenytoin, lamotrigine), a uricostatic drug and sulfonamides; some anti-infectives are also implicated.
  • Genetic predisposition: certain HLA alleles increase the risk, e.g. HLA-B*58:01 with exposure to a uricostatic drug, HLA-B*15:02 with carbamazepine (mainly in people of Asian ancestry) and HLA-B*13:01 with dapsone (in people of Chinese ancestry).
  • Mechanism: T cell-mediated delayed hypersensitivity (type IV).

Clinical features

  • Latency: typically 2 to 6 weeks after first intake; onset up to 12 weeks after starting the drug or after an increase in the amount is possible.
  • Skin and general symptoms: fever, widespread rash, facial edema, generalised edema and lymphadenopathy.
  • Organ involvement: hepatitis, pneumonitis and myocarditis; the kidneys may also be involved.
  • Course: symptoms may persist or recur for several weeks after exposure has ended; thyroiditis has been described as a late sequela.

Diagnosis

  • History: all drugs started in the preceding weeks, as the reaction appears only after days to weeks; not only the most recently started drug is suspect.
  • Full blood count: marked eosinophilia and atypical lymphocytes.
  • Organ assessment: liver tests, renal function and urinalysis; if myocarditis or pneumonitis is suspected, further cardiac and pulmonary investigations.
  • Skin biopsy: often suggestive but not diagnostic on its own.
  • Provocation tests: fundamentally excluded after DRESS syndrome.
  • HLA typing: can indicate risk for specific substances in certain populations.

Treatment principles

  • The culprit drug and possible cross-reacting substances are stopped immediately, and treatment takes place in hospital with supportive care and monitoring of organ function.
  • In significant organ involvement, systemic glucocorticoids are used and tapered slowly because of the tendency to relapse, while refractory cases require further immunosuppressants.
  • Follow-up is needed because of possible viral reactivation and later autoimmune disease such as thyroiditis; the reaction is recorded in an allergy passport.

Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.

Keep learning in the app

In the InnereFuchs app you can learn DRESS syndrome with flashcards, exam questions and image tasks (ECG, chest X-ray, ultrasound, lab values) – free, in your browser or as an app.

Open in browser  About InnereFuchs →

Further reading (open access)

  1. MSD Manual Professional: Drug Hypersensitivity
  2. MSD Manual Professional: Drug Eruptions and Reactions
  3. Renal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of 71 Cases

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.

Related pages: Alpha-gal syndrome · Angiedema (bradykinin- and histamine-mediated) · Food allergy

Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.